1-3 of 3
Ingrid Luise
Close
Save search
Sort by
Journal Articles

Financial Impact of Imatinib Discontinuation in Brazil - a Pharmoeconomic Study

Free
Renato Torrescasana Centrone, Isabel Bonafe, Eliana C Miranda, PhD, Fernanda S Seguro, MD, Gustavo HR Magalhaes, MD MSc, Nelma D Clementino, MD, Arthur Moellmann-Coelho, MD, Ingrid Luise, MD, Monika Conchon, MD, Natália N Gonçalves, MD, Jaisson Bortolini, MD, Laura Maria Fogliatto, MD PhD, Carmino Antonio Souza, MD PhD, Katia B Pagnano, MD PhD, Israel Bendit, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5844.
https://doi.org/10.1182/blood-2019-127530
Published: 2019
Journal Articles

Prognostic Impact of Deletion 17p Clone Size on Outcome in Chronic Lymphocytic Leukemia Patients (A Real Life Routine Practice Perspective in Brazil)

Free
Ricardo Bigni, MD MPH, Teresa de Souza Fernandez, PhD, Mayara Rego, MD, Ingrid Luise, MD, Eliana Abdelhay, PhD, Cecilia Fernandez, PhD, Keyla Araujo, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5546.
https://doi.org/10.1182/blood-2018-99-114843
Published: 2018
Journal Articles

Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study

Free
Katia B Pagnano, MD, Carmen Fava, Eliana C Miranda, Israel Bendit, MD PhD, Fernanda S Seguro, MD, Gustavo HR Magalhaes, MD, Nelma D Clementino, MD, Monika Conchon, MD, Natália N Gonçalves, MD, Gianluca Gaidano, MD PhD, Monia Lunghi, MD PhD, Arthur Moellmann-Coelho, MD, Ingrid Luise, MD, Micaela Bergamaschi, MD, Dario Ferrero, MD, Renato Centrone, MD, Patrizia Pregno, Laura Fogliatto, Valentina Giai, Matteo Emidio Dragani, MD, Elena Moiraghi, Jaisson Bortolini, MD, Andrea Castelli, Alessandra Cuttica, MD, Teresa Cristina Bortolheiro, MD, Cristiane Pinna, MD, Carmino Antonio De Souza, MD PhD, Giuseppe Saglio
Journal: Blood
Blood (2018) 132 (Supplement 1): 46.
https://doi.org/10.1182/blood-2018-99-113718
Published: 2018